Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers
NCT02413255
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
TAK-020
DRUG:
TAK-020 Placebo
Sponsor
Takeda